Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vaginal Neoplasms × Chemoradiotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Rectal Neoplasms 29 Esophageal Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 11 Carcinoma, Non-Small-Cell Lung 11 Nasopharyngeal Carcinoma 10 Uterine Cervical Neoplasms 8 Pancreatic Neoplasms 8 Oropharyngeal Neoplasms 8 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Mouth Neoplasms 4 Lung Neoplasms 4 Glioblastoma 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Neoplasms 4 Carcinoma, Squamous Cell 4 Adenocarcinoma 4 Pathologic Complete Response 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Breast Neoplasms 3 Thymoma 2 Resectable Esophageal Cancer 2 Radiation Injuries 2 Neoplasms 2 Nasopharyngeal Neoplasms 2 NSCLC 2 Lymphatic Metastasis 2 Laryngeal Neoplasms 2

Interventions

Radiotherapy 7 Brachytherapy 6 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Radiosurgery 3 Methods 3 tremelimumab 2 durvalumab 2 Topotecan 2 Radiation 2 Palliative Care 2 Paclitaxel 2 Gemcitabine 2 Early Intervention, Educational 2 Dehydroepiandrosterone 2 Capecitabine 2 Bevacizumab 2 Behavior Therapy 2 zimberelimab 1 temsirolimus 1 talazoparib 1 liposomal doxorubicin 1 fludarabine phosphate 1 dostarlimab 1 belzutifan 1 alovudine 1 aldesleukin 1 X-Rays 1 Vinorelbine 1 Vaginal Smears 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06314568 2025-08-15

TRIDENT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡